Kevin Petrie
Kevin Petrie
Lecturer in Cancer Biology, University of Stirling
Verified email at stir.ac.uk - Homepage
TitleCited byYear
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga, E Ballestar, A Villar-Garea, M Boix-Chornet, J Espada, ...
Nature genetics 37 (4), 391, 2005
17462005
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
T Schenk, WC Chen, S Göllner, L Howell, L Jin, K Hebestreit, HU Klein, ...
Nature medicine 18 (4), 605, 2012
4272012
Differentiation therapy of acute myeloid leukemia: past, present and future
K Petrie, A Zelent, S Waxman
Current opinion in hematology 16 (2), 84-91, 2009
1652009
Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia–associated TEL-AML1 oncoprotein
F Guidez, K Petrie, AM Ford, H Lu, CA Bennett, A MacGregor, ...
Blood 96 (7), 2557-2561, 2000
1582000
The histone deacetylase 9 gene encodes multiple protein isoforms
K Petrie, F Guidez, L Howell, L Healy, S Waxman, M Greaves, A Zelent
Journal of Biological Chemistry 278 (18), 16059-16072, 2003
1332003
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease
RM Hill, S Kuijper, JC Lindsey, K Petrie, EC Schwalbe, K Barker, ...
Cancer cell 27 (1), 72-84, 2015
922015
New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK
G Barone, J Anderson, ADJ Pearson, K Petrie, L Chesler
Clinical Cancer Research 19 (21), 5814-5821, 2013
832013
Targeting of AML1-ETO in t (8; 21) Leukemia by Oridonin Generates a Tumor Suppressor–Like Protein
T Zhen, CF Wu, P Liu, HY Wu, GB Zhou, Y Lu, JX Liu, Y Liang, KK Li, ...
Science translational medicine 4 (127), 127ra38-127ra38, 2012
742012
Lineage restriction of the RARα gene expression in myeloid differentiation
J Zhu, CM Heyworth, A Glasow, QH Huang, K Petrie, M Lanotte, G Benoit, ...
Blood 98 (8), 2563-2567, 2001
532001
Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells
EF Farias, K Petrie, B Leibovitch, J Murtagh, MB Chornet, T Schenk, ...
Proceedings of the National Academy of Sciences 107 (26), 11811-11816, 2010
412010
Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity
F Mussai, S Egan, S Hunter, H Webber, J Fisher, R Wheat, C McConville, ...
Cancer research 75 (15), 3043-3053, 2015
382015
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
A Glasow, A Barrett, K Petrie, R Gupta, M Boix-Chornet, DC Zhou, ...
Blood 111 (4), 2374-2377, 2008
372008
Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy
A Zelent, K Petrie, Z Chen, R Lotan, M Lübbert, MS Tallman, R Ohno, ...
Cancer research 65 (4), 1117-1123, 2005
252005
Marked for death
K Petrie, A Zelent
nature cell biology 10 (5), 507, 2008
232008
Cyclin-dependent kinase inhibitor AT7519 as a potential drug for MYCN-dependent neuroblastoma
MEM Dolman, E Poon, ME Ebus, IJM den Hartog, CJM van Noesel, ...
Clinical Cancer Research 21 (22), 5100-5109, 2015
222015
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
N Bansal, K Petrie, R Christova, CY Chung, BA Leibovitch, L Howell, V Gil, ...
Oncotarget 6 (33), 34087, 2015
202015
Selective inhibition of SIN3 corepressor with avermectins as a novel therapeutic strategy in triple-negative breast cancer
YJ Kwon, K Petrie, BA Leibovitch, L Zeng, M Mezei, L Howell, V Gil, ...
Molecular cancer therapeutics 14 (8), 1824-1836, 2015
202015
Histone deacetylase 9
A Zelent, K Petrie, F Guidez
US Patent 7,291,492, 2007
182007
p53 loss in MYC-driven neuroblastoma leads to metabolic adaptations supporting radioresistance
O Yogev, K Barker, A Sikka, GS Almeida, A Hallsworth, LM Smith, Y Jamin, ...
Cancer research 76 (10), 3025-3035, 2016
142016
Clinical translation of epigenetics in cancer: eN-CORe—a report on the second workshop
A Zelent, K Petrie, R Lotan, S Waxman, SD Gore
Molecular cancer therapeutics 4 (11), 1810-1819, 2005
142005
The system can't perform the operation now. Try again later.
Articles 1–20